For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
ASP003
D-Aspartic acid, N-[2-[[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethyl]-
AZA001
3-Azabicyclo[3.1.0]hexane,1-(4-methylphenyl)-
[71195-57-8]
Hydrochloride [66504-75-4]
AZA002
3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-
AZA003
3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-phenyl-
[66503-91-1]
AZA004
2-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester, (1S,3S,5S)-
[361440-67-7]
AZA005
3-Azabicyclo[3.1.0]hexane-3-carboxylic acid, 6,6-dimethyl-,1,1-dimethylethyl ester
AZA006
3-Azabicyclo[3.1.0]hexane-3-carboxamide,1-p-tolyl-
AZA007
7-Azabicyclo[4.1.0]heptane-7-carboxylic acid, 1,1-dimethylethyl ester
[153789-13-0]
AZA008
7-Azabicyclo[4.1.0]heptane, 7-[(4-methylphenyl)sulfonyl]-
[68820-12-2]
AZA009
7-Azabicyclo[4.1.0]heptane
[286-18-0]
AZA012
8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
[36505-84-7]
Hydrochloride [33386-08-2]
AZA013
2-Azabicyclo[3.1.0]hexane-1,2-dicarboxylic acid, 2-(1,1-dimethylethyl) ester
[1251004-87-1]
AZA014
Azabicyclo[2.2.2]octan-3-amine-,(3S)-
[120570-05-0]
Dihydrochloride [119904-90-4]
AZA015
2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-
[361440-68-8]
Hydrochloride [709031-39-0]
AZA016
3-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 6,6-dimethyl-, 3-(1,1-dimethylethyl) ester, (1R,2S,5S)-
[219754-02-6]
AZA017
3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 6,6-dimethyl-, methyl ester, (1R,2S,5S)-
[672325-23-4]
Hydrochloride [565456-77-1]
AZA018
3-Azabicyclo[3.1.0]hexane, 6,6-dimethyl-
[943516-54-9]
Hydrochloride [943516-55-0]
AZA019
3-Azabicyclo[3.1.0]hexane-2,4-dione, 6,6-dimethyl-
[194421-56-2]
AZA020
3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 6,6-dimethyl-, methyl ester, hydrochloride (1:1), (1S,2R,5R)-
[943516-62-9]
AZA021
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
[361441-98-7]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help